Free Trial

Inhibitor Therapeutics (INTI) Short Interest Ratio & Short Volume

Inhibitor Therapeutics logo
$0.06 +0.01 (+20.00%)
As of 04/1/2025 01:04 PM Eastern

Inhibitor Therapeutics Short Interest Data

Inhibitor Therapeutics (INTI) has a short interest of 21,100 shares, representing 0.01% of the float (the number of shares available for trading by the public). This marks a -60.85% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.7, indicating that it would take 0.7 days of the average trading volume of 47,177 shares to cover all short positions.

Current Short Interest
21,100 shares
Previous Short Interest
53,900 shares
Change Vs. Previous Month
-60.85%
Dollar Volume Sold Short
$1,477.00
Short Interest Ratio
0.7 Days to Cover
Last Record Date
March 15, 2025
Outstanding Shares
172,268,000 shares
Short Percent of Float
0.01%
Today's Trading Volume
166,999 shares
Average Trading Volume
47,177 shares
Today's Volume Vs. Average
354%
Short Selling Inhibitor Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Inhibitor Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

INTI Short Interest Over Time

INTI Days to Cover Over Time

INTI Percentage of Float Shorted Over Time

Remove Ads

Inhibitor Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/15/202521,100 shares $1,477.00 -60.9%0.0%0.7 $0.07
2/28/202553,900 shares $3,553.36 +36.8%0.0%539 $0.07
2/15/202539,400 shares $2,596.46 +471.0%0.0%0.5 $0.07
1/31/20256,900 shares $396.75 No ChangeN/A0.4 $0.06
1/15/202520,300 shares $1,215.97 -49.9%N/A0.7 $0.06
12/31/202420,300 shares $1,220.03 -49.9%N/A0.7 $0.06
12/15/202440,500 shares $2,997.00 +841.9%N/A0.2 $0.07
11/30/20244,300 shares $331.10 -43.4%N/A0.1 $0.08
11/15/20247,600 shares $608.00 -32.7%N/A0.1 $0.08
10/31/202411,300 shares $960.50 No ChangeN/A0.4 $0.09
7/15/2024100 shares $8.50 -50.0%N/A1 $0.09
6/30/2024200 shares $15.80 -86.7%N/A0.1 $0.08
6/15/20241,500 shares $105.15 +15.4%N/A5 $0.07
5/31/20241,300 shares $113.88 No ChangeN/A0.1 $0.09
4/30/20242,300 shares $197.80 No ChangeN/A1.8 $0.09
4/15/20242,300 shares $178.25 +360.0%N/A0.5 $0.08
3/31/2024500 shares $35.00 +400.0%N/A0 $0.07
3/15/2024100 shares $7.70 -99.6%N/A0 $0.08
2/29/202424,800 shares $1,984.00 No ChangeN/A0.5 $0.08
11/30/2023100 shares $9.05 -94.1%N/A0 $0.09
11/15/20231,700 shares $204.00 +1,600.0%N/A0.1 $0.12
10/31/2023100 shares $5.15 -98.2%N/A0 $0.05
10/15/20235,600 shares $268.80 No ChangeN/A1 $0.05
9/30/20235,600 shares $302.40 -73.1%N/A0.4 $0.05
9/15/202320,800 shares $1,123.20 No ChangeN/A0.3 $0.05
8/15/20232,400 shares $49.92 No ChangeN/A0 $0.02
5/31/20231,500 shares $48.00 -25.0%N/A0.2 $0.03
5/15/20232,000 shares $78.00 No ChangeN/A0.1 $0.04
11/15/20223,300 shares $198.00 +37.5%N/A0.1 $0.06
10/31/20222,400 shares $117.12 No ChangeN/A3 $0.05
10/15/20222,400 shares $105.48 No ChangeN/A4.8 $0.04
9/30/20222,400 shares $123.60 +118.2%N/A0.2 $0.05
9/15/20221,100 shares $97.68 No ChangeN/A0 $0.09
8/31/20221,100 shares $97.68 No ChangeN/A0 $0.09
4/30/2022100 shares $14.38 No ChangeN/A0.3 $0.14
4/15/2022100 shares $14.39 -50.0%N/A0 $0.14
3/31/2022200 shares $26.10 No ChangeN/A0.3 $0.13
3/15/2022200 shares $31.56 No ChangeN/A2 $0.16
2/28/2022200 shares $31.56 No ChangeN/A0.7 $0.16
2/15/2022200 shares $26.07 No ChangeN/A0.1 $0.13
“Amazon Coin” set to outperform Bitcoin (Ad)

Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... But today, Chris is now making the biggest crypto call of his ENTIRE career…

1/31/2022200 shares $26.11 No ChangeN/A0.1 $0.13
11/15/20212,000 shares $318.60 No ChangeN/A0.1 $0.16
10/15/20213,000 shares $480.00 No ChangeN/A0.1 $0.16
9/30/20213,000 shares $450.90 +500.0%N/A0.3 $0.15
9/15/2021500 shares $61.05 -16.7%N/A0.5 $0.12
8/31/2021600 shares $79.80 No ChangeN/A0 $0.13
8/13/2021600 shares $120.18 No ChangeN/A0 $0.20
7/30/2021600 shares $144.00 -79.3%N/A0.1 $0.24
7/15/20212,900 shares $697.45 +26.1%N/A0.8 $0.24
6/30/20212,300 shares $553.38 +2,200.0%N/A0 $0.24
6/15/2021100 shares $12.00 -88.9%N/A0 $0.12
5/28/2021900 shares $71.01 -10.0%N/A0.1 $0.08
5/14/20211,000 shares $75.20 +900.0%N/A0.1 $0.08
4/30/2021100 shares $6.50 -98.4%N/A0 $0.07
4/15/20216,300 shares $472.50 +65.8%N/A0.8 $0.08
3/31/20213,800 shares $286.90 +660.0%N/A0.6 $0.08
3/15/2021500 shares $55.00 No ChangeN/A0 $0.11
2/12/20218,500 shares $462.40 No ChangeN/A0.2 $0.05
11/30/2020200 shares $7.44 No ChangeN/A0 $0.04

INTI Short Interest - Frequently Asked Questions

What is Inhibitor Therapeutics' current short interest?

Short interest is the volume of Inhibitor Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 21,100 shares of INTI short. 0.01% of Inhibitor Therapeutics' shares are currently sold short. Learn More on Inhibitor Therapeutics' current short interest.

What is a good short interest ratio for Inhibitor Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. INTI shares currently have a short interest ratio of 1.0. Learn More on Inhibitor Therapeutics's short interest ratio.

What is a good short interest percentage for Inhibitor Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.01% of Inhibitor Therapeutics' floating shares are currently sold short.

Is Inhibitor Therapeutics' short interest increasing or decreasing?

Inhibitor Therapeutics saw a decrease in short interest in the month of March. As of March 15th, there was short interest totaling 21,100 shares, a decrease of 60.9% from the previous total of 53,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Inhibitor Therapeutics' short interest compare to its competitors?

0.01% of Inhibitor Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Inhibitor Therapeutics: Atara Biotherapeutics, Inc. (19.03%), Verrica Pharmaceuticals Inc. (8.48%), Lantern Pharma Inc. (2.98%), Dyadic International, Inc. (0.47%), SCYNEXIS, Inc. (1.89%), KALA BIO, Inc. (5.49%), ALX Oncology Holdings Inc. (18.80%), Xilio Therapeutics, Inc. (3.47%), MariMed Inc. (0.02%), Prelude Therapeutics Incorporated (6.35%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks.

What does it mean to sell short Inhibitor Therapeutics stock?

Short selling INTI is an investing strategy that aims to generate trading profit from Inhibitor Therapeutics as its price is falling. INTI shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Inhibitor Therapeutics?

A short squeeze for Inhibitor Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INTI, which in turn drives the price of the stock up even further.

How often is Inhibitor Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INTI, twice per month. The most recent reporting period available is March, 15 2025.




This page (OTCMKTS:INTI) was last updated on 4/2/2025 by MarketBeat.com Staff
From Our Partners